Growth Metrics

Fulgent Genetics (FLGT) Short term Debt (2020 - 2025)

Fulgent Genetics (FLGT) has disclosed Short term Debt for 6 consecutive years, with $28.1 million as the latest value for Q4 2025.

  • Quarterly Short term Debt rose 1.94% to $28.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $28.1 million through Dec 2025, up 1.94% year-over-year, with the annual reading at $28.1 million for FY2025, 1.94% up from the prior year.
  • Short term Debt hit $28.1 million in Q4 2025 for Fulgent Genetics, down from $28.5 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $28.5 million in Q3 2025 to a low of $574000.0 in Q2 2021.
  • Historically, Short term Debt has averaged $20.1 million across 5 years, with a median of $18.9 million in 2023.
  • Biggest five-year swings in Short term Debt: surged 8082.16% in 2021 and later decreased 0.91% in 2022.
  • Year by year, Short term Debt stood at $15.1 million in 2021, then decreased by 0.91% to $15.0 million in 2022, then skyrocketed by 51.34% to $22.7 million in 2023, then increased by 21.63% to $27.6 million in 2024, then increased by 1.94% to $28.1 million in 2025.
  • Business Quant data shows Short term Debt for FLGT at $28.1 million in Q4 2025, $28.5 million in Q3 2025, and $27.6 million in Q2 2025.